about
Conservative laser microsurgery for T1 glottic carcinoma.Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancersFertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.First-line treatment of advanced ovarian cancer: current research and perspectives.Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.PCR assay to detect Bacillus anthracis spores in heat-treated specimens.Loss of p27 expression through RAS-->BRAF-->MAP kinase-dependent pathway in human thyroid carcinomas.Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers.Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.Detection of anthrax vaccine virulence factors by polymerase chain reaction.Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update.Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.Prevalence of "unclassified" HPV genotypes among women with abnormal cytologyBRAF mutation and RASSF1A expression in thyroid carcinoma of southern ItalyUSP1 links platinum resistance to cancer cell dissemination by regulating Snail stabilityIn vivo effects of recombinant-interferon-beta1b treatment on polymorphonuclear cell and monocyte functions and on T-cell-mediated antibacterial activity in patients with relapsing-remitting multiple sclerosisMetastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 yearsConservative treatment of early endometrial cancer: preliminary results of a pilot studyRewarding peer-review work: the Publons initiative
P50
Q33301409-034F8328-1E89-4DAE-9C2A-A8CFCFF02EB6Q33798276-A5FCED85-DADA-449B-B4F5-DC1B8A605008Q34100895-2B7D0518-454A-4A2E-8D0F-1586E6571CCAQ35741674-B956B27B-AE55-4EC4-8B3A-114C00C6254FQ37375359-53F8EFEE-078B-483A-AFCB-74B62A961838Q37512356-F3120BE8-A1F7-4444-B776-94AE96693C3EQ37656214-78F5D3D5-DAD8-49E8-9E59-7DB5A6A09D10Q37687273-1A1B0A1B-1570-4C3A-80E8-AB1353CAC595Q38312260-A5D9BA14-0139-4CE9-9DE1-CFA89A755FEAQ38610046-E0ADCFAE-FBC8-41F8-9C9E-102FCC5DE4AAQ38628722-81730569-BBB1-4E2D-88A8-159FDC7F2C03Q38684486-E089C85F-1265-474E-86E1-0D8FF92682C3Q39733188-995BD07D-3784-4E3F-8FB7-18CBAD5E014CQ40046090-F66642AB-14C1-4453-A258-47644FA24FC5Q40505626-C9BA4CAC-F247-4F55-9FEE-03A51DE0D916Q41830039-CA9B8C6C-A4B9-4FAA-81BF-8047199DF137Q43456129-712FAEB1-29B1-4D7C-A8AB-2CDE2CF8B2D7Q43678382-098426E1-FF82-413C-B6A1-9043B12CAAFFQ44672148-0137EF8B-F6BF-4DD8-AE94-DCB6A2ADD4A6Q46098079-B278842E-5953-421D-AF6A-41F5FD93E95CQ47373692-74CF6A66-D03F-499F-9203-F587A05BAAFAQ51325020-F0F8AFCE-E002-484E-A6BE-F7C1E544256FQ51778537-248E32C4-EB42-4869-98AE-B726021804EAQ52860239-F8224D36-3490-4D8C-BDC3-1281AC50DD7DQ53919011-EC75D6D4-28C5-444C-89A6-A1A651EFB323Q54244551-6F3E50BB-9399-4C6A-9913-17B7339B8DC6Q59355661-18CC0F69-4C4B-48CC-9900-BC4942CD7F0EQ60590414-2C28EDB5-C8EE-4DD6-9F33-5DFECB0155A0Q64062880-5ABB9F30-8695-4FA7-9D12-036F928851EAQ73592914-825A9283-53F3-4129-BD0B-9EE2356FA75EQ80119186-AD369D60-DDC5-44E8-A6FD-CDE6BFD1A45BQ82261895-FA4A9B01-8170-41AC-B8F9-46D740B275F4Q89901945-9D1F0397-D3E5-4DAE-B7D5-94392E47B2AC
P50
description
researcher
@en
name
Losito S
@nl
Simona Losito
@en
type
label
Losito S
@nl
Simona Losito
@en
altLabel
Nunzia Losito
@en
prefLabel
Losito S
@nl
Simona Losito
@en
P106
P31
P496
0000-0001-9045-0328